Clinical studies indicate that in individuals with T2DM and obesity, oral semaglutide at a dose of 14 mg can improve HbA1c levels by up to 1.4% and reduce body weight by approximately 4.4 kg.95 A 68-week phase III trial assessed the efficacy and safety of daily oral semaglutide 50 mg combined with moderate-intensity lifestyle interventions versus placebo in a cohort of obese individuals without T2DM
While simply addressing inflammation is not sufficient for treating hyperthyroidism, it is often the first step to regaining control of autoimmune disorders
L-Carnitine is something your body already naturally makes
[END CALLOUT BOX] GLP2 Research Applications & Key Findings Type 2 Diabetes Management SURPASS Clinical Trial Program The SURPASS phase 3 clinical program enrolled over 6,000 participants across five global registration trials, evaluating GLP2 across the type 2 diabetes treatment continuum
Some clients come weekly for ongoing support, while others use IV therapy as needed for recovery, immunity, or energy
It is studied in animal research for its effects on the healing and repair of tissues such as tendon, muscle and gut lining